Heat Biologics Secures $5,050,050 New Round

  • Feed Type
  • Date
    4/10/2013
  • Company Name
    Heat Biologics
  • Mailing Address
    100 Europa Drive Chapel Hill, NC 27517 USA
  • Company Description
    Heat Biologics (Heat) is a clinical-stage company focused on the development and commercialization of its HS-System, a platform technology that offers a novel approach to treating cancer and other diseases by using live, modified cell lines to activate the immune system against specific defined targets.
  • Website
    http://www.heatbio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,050,050
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor